Kahn Linda S, Mendel Whitney E, Fallin Kyla L, Borngraber Elizabeth A, Nochajski Thomas H, Rea William E, Blondell Richard D
a Department of Family Medicine , Primary Care Research Institute, University at Buffalo , Buffalo , NY , USA.
b Master of Public Health Program, Daemen College , Amherst , NY , USA.
Soc Work Health Care. 2017 Aug;56(7):649-665. doi: 10.1080/00981389.2017.1327470. Epub 2017 Jun 8.
Opioid use during pregnancy poses serious risks for the mother and the unborn child. Opioid-use disorder may be managed with medication-assisted treatment (MAT) in an outpatient setting, but few MAT practices specifically address the challenges faced by pregnant women. This article describes a medical office-based educational support group for women in MAT for opioid-use disorder who were pregnant and/or parenting young children. Focus groups were conducted to elicit patient feedback. Women indicated that they found the educational support groups beneficial and offered suggestions. In-office educational support groups for pregnant women in treatment for opioid-use disorder are feasible and well received.
孕期使用阿片类药物会给母亲和未出生的孩子带来严重风险。阿片类药物使用障碍可在门诊环境中通过药物辅助治疗（MAT）进行管理，但很少有MAT实践专门解决孕妇面临的挑战。本文描述了一个以医疗办公室为基础的教育支持小组，该小组面向患有阿片类药物使用障碍且正在接受MAT治疗的孕妇和/或育有幼儿的女性。通过焦点小组来获取患者反馈。女性表示她们发现教育支持小组很有益，并提出了建议。为患有阿片类药物使用障碍的孕妇设立的办公室内教育支持小组是可行的，并且很受欢迎。
